114 related articles for article (PubMed ID: 37878765)
21. No Association between Radiation Dose from Pediatric CT Scans and Risk of Subsequent Hodgkin Lymphoma.
Berrington de Gonzalez A; Journy N; Lee C; Morton LM; Harbron RW; Stewart DR; Parker L; Craft AW; McHugh K; Little MP; Pearce MS
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):804-806. PubMed ID: 28052939
[No Abstract] [Full Text] [Related]
22. Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India.
Nayak L; Jain H; Bonda A; Epari S; Laskar S; Gokarn A; Shet T; Gujral S; Khanna N; Bagal B; Punatar S; Goda J; Thorat J; Rengaraj K; Sengar M
J Adolesc Young Adult Oncol; 2021 Oct; 10(5):581-587. PubMed ID: 33090916
[No Abstract] [Full Text] [Related]
23. Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
Fernández KS; Schwartz CL; Chen L; Constine LS; Chauvenet A; de Alarcón PA
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612375
[TBL] [Abstract][Full Text] [Related]
24. Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study.
Gupta S; Baxter NN; Hodgson D; Punnett A; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
Cancer Med; 2020 Oct; 9(19):6933-6945. PubMed ID: 32441450
[TBL] [Abstract][Full Text] [Related]
25. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
26. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation.
Feugier P; Labouyrie E; Djeridane M; Jenabian A; Dubruille V; Berthou C; Ghandour C; Desablens B; Chaït Y; Casassus P; Delwail V; Ifrah N; Le Mevel A; Lamy T; Brière J; Colonna P; Andrieu JM
Blood; 2004 Nov; 104(9):2675-81. PubMed ID: 15231567
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
28. Short-Term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients.
Wooten SV; Roth M; Livingston JA; Hildebrandt MAT; Chandra J; Amini B; Kleinerman ES; Gilchrist SC
J Adolesc Young Adult Oncol; 2022 Jun; 11(3):320-322. PubMed ID: 34388045
[TBL] [Abstract][Full Text] [Related]
29. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
[TBL] [Abstract][Full Text] [Related]
30. Thoracic wall involvement by Hodgkin disease and non-Hodgkin lymphoma: CT evaluation.
Press GA; Glazer HS; Wasserman TH; Aronberg DJ; Lee JK; Sagel SS
Radiology; 1985 Oct; 157(1):195-8. PubMed ID: 4034966
[TBL] [Abstract][Full Text] [Related]
31. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
El-Galaly TC; Hutchings M; Mylam KJ; Brown Pde N; Bukh A; Johnsen HE; Kamper P; Loft A; Iyer V; Gormsen LC; Nielsen AL; Bøgsted M; d'Amore F
Leuk Lymphoma; 2014 Oct; 55(10):2349-55. PubMed ID: 24354682
[TBL] [Abstract][Full Text] [Related]
32. Quantification of chemotherapy-induced changes in body composition in pediatric, adolescent, and young adult lymphoma using standard of care CT imaging.
Tram NK; Chou TH; Ettefagh LN; Deep K; Bobbey AJ; Audino AN; Stacy MR
Eur Radiol; 2022 Oct; 32(10):7270-7277. PubMed ID: 35947147
[TBL] [Abstract][Full Text] [Related]
33. Weight Changes In Patients With Hodgkin Lymphoma Following Treatment: Experience From A Cancer Hospital.
Ali J; Siddiqui N; Hameed A
J Ayub Med Coll Abbottabad; 2016; 28(4):738-741. PubMed ID: 28586610
[TBL] [Abstract][Full Text] [Related]
34. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients.
Rossi C; Kanoun S; Berriolo-Riedinger A; Dygai-Cochet I; Humbert O; Legouge C; Chrétien ML; Bastie JN; Brunotte F; Casasnovas RO
J Nucl Med; 2014 Apr; 55(4):569-73. PubMed ID: 24566003
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
[TBL] [Abstract][Full Text] [Related]
36. Utility of Echocardiography as Screening for Late-onset Anthracycline-induced Cardiotoxicity in Pediatric Cancer Survivors: Observations from the First Decade After End of Therapy.
Moke DJ; Schubert LE; Sun HY; Printz BF; Dietz AC
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e283-e288. PubMed ID: 29432303
[TBL] [Abstract][Full Text] [Related]
37. Radiation Therapy for Treatment of Adolescent and Young Adult Hodgkin Lymphoma and Risk for Cardiovascular Disease and Cancer.
Rugbjerg K; Olsen JH
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):1-8. PubMed ID: 30192163
[TBL] [Abstract][Full Text] [Related]
38. Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies.
Xavier AC; Costa LJ
Leuk Lymphoma; 2015; 56(8):2339-43. PubMed ID: 25393805
[TBL] [Abstract][Full Text] [Related]
39. Degree of fatness after treatment of malignant lymphoma in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
Med Pediatr Oncol; 2003 Apr; 40(4):239-43. PubMed ID: 12555252
[TBL] [Abstract][Full Text] [Related]
40. Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Kuruvilla J; Ramchandren R; Santoro A; Paszkiewicz-Kozik E; Gasiorowski R; Johnson NA; Fogliatto LM; Goncalves I; de Oliveira JSR; Buccheri V; Perini GF; Goldschmidt N; Kriachok I; Dickinson M; Komarnicki M; McDonald A; Ozcan M; Sekiguchi N; Zhu Y; Nahar A; Marinello P; Zinzani PL;
Lancet Oncol; 2021 Apr; 22(4):512-524. PubMed ID: 33721562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
